Warfarin interaction with Matricaria chamomilla
Open accessThe DOI matches its Crossref record.
Abstract
No cases have been reported of Matricaria chamomilla potentiating the effects of warfarin. Nevertheless there is a theoretical risk for potentiation, since the herb is thought to be a coumarin constituent. We describe the case of a 70-year-old woman who, while being treated with warfarin, was admitted to hospital with multiple internal hemorrhages after having used chamomile products (tea and body lotion) to soothe upper respiratory tract symptoms. Patient education on the potential risk of taking chamomile products while being treated with warfarin is necessary to avoid such occurrences.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Yeung, K. S., Hernandez, M., Mao, J. J., Haviland, I., & Gubili, J. (2018) · Phytotherapy Research · doi:10.1002/ptr.6033 · Cited by 229
“In addition, herbs such as chamomile (Segal and Pilote, 2006) and lavender (Denner, 2009) have anticoagulant/antiplatelet properties, and may therefore elevate the risk of bleeding with concurrent use of drugs that have similar actions (Ge et al., 2014).”
BackgroundIdentification of drugs that interact with herbs in drug development
Zhou, S.-F., Zhou, Z.-W., Li, C.-G., Chen, X., Yu, X., Xue, C. C., & Herington, A. (2007) · Drug Discovery Today · doi:10.1016/j.drudis.2007.06.004 · Cited by 178
“chamomilla Case series; 7PTS ↓ INR Enzyme induction [77, 105 ]”
BackgroundOrellana-Paucar, A., & Vintimilla-Rojas, D. (2020) · Systematic Reviews · doi:10.1186/s13643-019-1259-2 · Cited by 53
Metadata
- Authors
- Segal, R.
- Venue
- Canadian Medical Association Journal
- Publisher
- CMA Joule Inc.
- Published
- 2006-04-25
- Volume
- 174
- Issue
- 9
- Pages
- 1281-1282
- ISSN
- 0820-3946 (ISSN-L)
- 1488-2329
- OpenAlex
- W2129191856
- Cited by
- 107
- References
- 0
- FWCI
- 13.13
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.